All In MedTech

Device Trial Radar · NCT07650448

WATER IV PCa (AS Sub-study)

WATER IV Prostate Cancer: Aquablation Versus Active Surveillance for the Treatment of Localized Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 333 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

333

Planned (sponsor's estimate)

Start

Sep 11, 2026

Primary completion

Dec 2028

Study completion Dec 2038

Sponsor

Lead sponsor
PROCEPT BioRoboticsPublic (PRCT)
Sponsor type
Industry
First posted
Jun 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Conditions

  • Localized Prostate Cancer

Interventions

  • Aquablation TherapyDevice

    The AquaBeam Robotic System and the HYDROS Robotic System utilize high-velocity sterile saline waterjet to resect prostate tissue, guided by real-time visualization through cystoscopy and transrectal ultrasound imaging. This minimally invasive surgical procedure is called the Aquablation therapy.

  • Active SurveillanceOther

    Active surveillance is a management strategy for men with low- and favorable intermediate-risk localized prostate cancer that involves close monitoring with curative intent, reserving treatment for evidence of disease progression. Monitoring typically includes serial PSA testing, periodic prostate MRI, and repeat biopsies at scheduled intervals, with intervention triggered by evidence of disease progression.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from GG ≥ 2Time frame: 12 Months

Locations

28 sites in 2 countries. Site status is shown where the registry gives one.

  • Arizona State Urological Institute

    Chandler, Arizona · Not yet recruiting

  • University of Southern California

    Los Angeles, California · Recruiting

  • Tri Valley Urology

    Murrieta, California · Not yet recruiting

25 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.